Drug intelligence / Profile preview

Bovine Albumin Concentrate

Development stage: Preclinical
Lead developer: Metabolic Technologies Inc.
Modality: Recombinant Proteins and Enzymes
Administration: Oral

Overview

Bovine Albumin Concentrate is a protein-based dietary supplement derived from bovine albumin. It is being investigated for its effect on plasma amino acid levels. A clinical trial is underway to compare how quickly and to what extent plasma amino acid levels rise after ingesting a single dose of Bovine Albumin Concentrate versus whey protein, with the anticipation that its amino acids will rise similarly to whey protein. This research aims to understand its biological availability and efficacy as a nutritional option.

Beyond the preview

Go deeper on Bovine Albumin Concentrate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bovine Albumin Concentrate.

Explore the full profile